$IMVT
Immunovant, Inc.
Nasdaq · Healthcare · Biological Products, (No Diagnostic Substances) · Durham, NC
IMVT chart
What traders are saying about $IMVT
Latest postsImmunovant, Inc. news
- Truist Securities maintains Immunovant at Hold, raises price target to $33 from $30
TradingView ·
- Wells Fargo maintains Immunovant at Overweight, raises price target to $47 from $45
TradingView ·
- Why Immunovant (IMVT) Is Up 15.1% And What's Next
Simply Wall St ·
- Immunovant (IMVT) Q2 2027 Earnings Call Transcript
fool.com ·
- Immunovant, Inc. Q2 2027 Earnings Call Summary
app.moby.co ·
- HanAll partner Immunovant's arthritis drug meets primary goal, misses secondary endpoints
Korea Biomedical Review ·
- Immunovant Stock What Changed After Arthritis Trial Success
Yahoo Finance ·
- Immunovant stock: IMVT-1402 RA result sets up FDA path decision
ad-hoc-news.de ·
- Immunovant, Inc. Stock 12‑Month Price Target Cut to $48, Implies 57% Upside
TradingView ·
- Why Is Immunovant Stock Soaring Today? - Immunovant (NASDAQ:IMVT)
Benzinga ·
- What Immunovant (IMVT) Said on Its Q2 Earnings Call
marketbeat.com ·
- Immunovant Fiscal Q2 Net Loss Narrows
Moomoo ·
Immunovant, Inc. key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Net income | -$505.6M | -$413.8M | -$259.3M | -$211.0M |
| Diluted EPS | $-2.77 | $-2.73 | $-1.88 | $-1.71 |
| Total assets (year end) | $1.05B | $420.9M | $711.4M | $456.2M |
| Cash and equivalents (year end) | $994.5M | $374.7M | $690.9M | $432.6M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Immunovant, Inc.
- Ticker
- IMVT (Nasdaq)
- Industry
- Biological Products, (No Diagnostic Substances)
- Headquarters
- Durham, NC
- Incorporated in
- DE
- Fiscal year end
- March 31
- SEC CIK
- 1764013
- Former names
- Health Sciences Acquisitions Corp
Frequently asked questions
What exchange is Immunovant, Inc. listed on?
Immunovant, Inc. trades on the Nasdaq under the ticker symbol IMVT.
What industry is Immunovant, Inc. in?
Immunovant, Inc. is classified by the SEC under "Biological Products, (No Diagnostic Substances)", part of the Healthcare sector on StockTweeting.
Where is Immunovant, Inc. headquartered?
Immunovant, Inc.'s business address on file with the SEC is in Durham, NC.
When does Immunovant, Inc.'s fiscal year end?
Immunovant, Inc.'s fiscal year ends on March 31.